Answers are grounded in this paper and cite their sources.
Historically, whole brain radiotherapy was administered to most patients with brain metastases. However, over the past three decades, stereotactic radiosurgery (SRS), targeted at individual cranial lesions, has been accepted widely. In this study, based on the authors' experiences along with published data, recent trends in SRS for brain metastases are discussed. This article focuses on the following issues: 1) How many tumors can or should be treated with SRS? 2) Two-/three-staged SRS for relatively large tumors, 3) post- or preoperative SRS, and 4) repeat SRS.
No takes yet. Share an insight, caveat, or question.
Higuchi et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: